Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life.
Arwen H Pieterse, Marleen Kunneman, Wilbert B van den Hout...
https://pubmed.ncbi.nlm.nih.gov/30971150Actively Recruiting
Age: 18Years +
All Genders
Healthy Volunteers
ID04925154
PATHOS Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality of Life
Led by Sir Mortimer B. Davis - Jewish General Hospital · Updated on 2026-05-14
192
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating how patients with operable rectal cancer and physicians make decisions about treatment options, focusing on their treatment preferences and socioeconomic and demographic backgrounds. The study also explores the balance between treatment benefits and quality of life. This observational study involves 192 participants, including 178 patients and 14 healthcare professionals, to better understand the thought processes behind treatment choices. Participants will complete two electronic questionnaires. The first gathers socio-demographic data, clinical information, and current knowledge about treatments. After this, all participants receive an informational brochure describing common treatment options, such as standard care, non-operative management, and surgery, including details about treatment length, potential side effects, and cancer outcomes. The second questionnaire assesses participants' treatment preferences and the tradeoffs they consider between benefits and quality of life. Participants are approached at clinical visits or through the research team and provide electronic consent before participation. All study materials, including consent forms, brochures, and questionnaires, are delivered electronically. The primary outcome measures include socio-economic and demographic characteristics, while secondary measures focus on the level of tradeoff participants make between treatment benefits and quality of life. The study is expected to conclude by January 2028.
CONDITIONS
Brief Title
Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- New rectal cancer patient
- Operable patients
- Adults 18 years or older
- Able to sign a consent form
- Able to answer questionnaires online
- Treating physician specialists
- Able to sign a consent form
- Able to answer questionnaires online
You will not qualify if you...
- Unable to sign a consent form (patients and physicians)
- Patients with metastasis
- Patients with recurrent tumours
- Unable to answer questionnaires online
- Unable to communicate in French or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Questionnaire Completion and Information Provision
Duration - 2 to 3 weeks
Participants who consent complete initial questionnaires about socio-demographic and clinical data, then receive an informational brochure about treatment options.
Questionnaires and brochure provided electronically; no in-person visits required
Treatment Preferences Assessment
Duration - 1 day
Participants complete a second questionnaire evaluating their treatment preferences and tradeoff between benefits and quality of life.
1 electronic questionnaire completion
Trial Site Locations
Total: 1 location
1
Jewish General Hospital
Montreal, Quebec, Canada, H3T 1E2
Actively Recruiting
Loading map...
Research Team
E
Emma Starr, BHSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Transanal Endoscopic Microsurgery.
Theodore John Saclarides
https://pubmed.ncbi.nlm.nih.gov/26491409Transanal endoscopic microsurgery (TEM) for T1 rectal cancer.
Léon Maggiori, Yves Panis
https://pubmed.ncbi.nlm.nih.gov/23373364Transanal endoscopic microsurgery.
Chris Cunningham
https://pubmed.ncbi.nlm.nih.gov/25102997Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
Angelita Habr-Gama, Jorge Sabbaga, Joaquim Gama-Rodrigues...
https://pubmed.ncbi.nlm.nih.gov/24022527Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer.
Aurelie Garant, Sindy Magnan, Slobodan Devic...
https://pubmed.ncbi.nlm.nih.gov/31476417Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial.
Maxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten...
https://pubmed.ncbi.nlm.nih.gov/32240909Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?
Maxime J M van der Valk, Marit E van der Sande, Renee E Toebes...
https://pubmed.ncbi.nlm.nih.gov/32336626Surgeons' Views on Shared Decision-Making.
Suraj Kannan, Jayhyun Seo, Kevin R Riggs...
https://pubmed.ncbi.nlm.nih.gov/32002443Evaluation of the treatment tradeoff method in rectal cancer patients: is surgery preference related to outcome utilities?
Ercolie R Bossema, Corrie A M Marijnen, Monique C M Baas-Thijssen...
https://pubmed.ncbi.nlm.nih.gov/18519887